bpc-157 peptide benefits risks research The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity The Hidden Risks of BPC‑157:

However, human clinical trials are limited and hence, this peptide should not be regarded as a treatment for cancer

FAQ How long before I notice effects from MOTS-C

[6] If this happens, vitamin B 12 deficiency may result in sense loss, loss of sensation in the feet, difficulty walking, poor balance, blurred vision, changes in reflexes, muscle weakness, decreased smell and taste, decreased level of consciousness, mood changes, memory loss, depression, irritability, clumsiness, disorientation, dementia and, in severe cases, psychosis

At room temperature, you're looking at a viable lifespan measured in hours, not days or weeks